MedPlus Health Services Q1 FY27 Earnings Call Transcript Released
MedPlus Health Services released its Q1 FY27 earnings call transcript. The company added a net of 146 stores, reaching 5,476. Consolidated revenue was ₹1879.6 crore with EBITDA at ₹65.1 crore. Capex proposals for food park and wellness facilities are on hold due to market feedback. Private label sales were 20% of revenue.
The announcement details the company's financial performance for the quarter and strategic decisions regarding capex and store expansion. The decision to put capex on hold might impact future growth plans, while the continued store additions and revenue performance are significant for investors.
The announcement is a transcript of an earnings call, which is a routine disclosure. While it provides financial updates and strategic decisions like putting capex on hold, it does not contain overwhelmingly positive or negative news. The decision to halt capex could be viewed negatively, but the continued store expansion and revenue growth are positive.
MedPlus Health Services Limited has released the transcript of its Earnings Call held on July 22, 2026, to discuss the financial results for the first quarter of FY27, ending June 30, 2026. The company added a net of 146 stores in the current quarter, bringing the total network to 5,476 stores. Consolidated revenue for the quarter was ₹18,796 million (1879.6 crore), with operating EBITDA at ₹651 million (65.1 crore), representing 3.5% of revenue. Pharmacy revenue grew 21.8% year-on-year, with pharmacy operating EBITDA at ₹588 million (58.8 crore). Diagnostics revenue increased to ₹370.8 million (37.08 crore), with an operating EBITDA of ₹65.9 million (6.59 crore).
During the call, the company announced that capex proposals, including those for a food park and a wellness services facility, have been put on hold. Management cited market reaction and investor feedback as reasons for this decision. The company aims to utilize its balance sheet funds effectively. Private label sales constituted 20% of total revenue, with a slight degrowth in percentage terms year-on-year, attributed to a focus on customer service over aggressive pushing. However, absolute sales of private label products are growing.
The company is adjusting its discount structure for sales over ₹1,000, reducing the discount from 20% to 19% for a large number of customers. The private label subscription base stands at approximately 44-45 lakh active clients, with an increase in membership fees from ₹99 to ₹149, expected to impact the top line by ₹10-11 crore annually. Employee expenses have increased due to warehouse additions and wage hikes in Karnataka and Telangana. MedPlus continues its strategy of contiguous expansion in existing states and plans to add 800 net new stores in FY27, with a 50-50 mix between franchisee and company-owned stores.
What to do with a filing like this
Medplus Health Services Limited filed this with the NSE as a statutory disclosure, categorised under concall transcript released. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Medplus Health Services Limited. Read the original for the full detail.